As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Obesity in India is a family problem, not an individual one, with sedentary lifestyles and unhealthy diets leading to weight ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

Kombucha's popularity in India grows, but scientific evidence lags; new study explores gut microbiome effects for health.

MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

A study by AIIMS-Delhi and ICMR found no link between COVID-19 vaccination and sudden cardiac arrests in young individuals, ...

Polycystic Ovary Syndrome (PCOS), a complex hormonal disorder has emerged as a significant health concern in India, affecting ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...